Table 3.
Serum fibrosis indexes in patients with different fibrosis stage of IHS (mean ± SD, μg/L)
| Group | Patients (n) | HA | PC- III | C IV | LN |
| Control group | 46 | 225.18 ± 80.58 | 432.32 ± 166.68 | 129.69 ± 33.08 | 141.63 ± 34.63 |
| Mild group | 12 | 352.11 ± 157.33a | 445.73 ± 191.11 | 149.85 ± 49.27 | 151.22 ± 36.57 |
| Moderate group | 12 | 447.48 ± 175.57b | 480.77 ± 217.15 | 141.91 ± 47.51 | 132.56 ± 41.29 |
| Severe group | 15 | 745.32 ± 231.12bd | 580.36 ± 147.79 a | 185.00 ± 45.82b | 167.90 ± 29.41a |
HA, Serum hyaluronic acid; PC- III: Pre-Collagen type III; C-IV: Collagen type IV; LN: Laminin.
a
P < 0.05, and
b
P < 0.01 vs control group;
d
P < 0.01, vs mild and moderate group.